Bibliographic record

Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase…

Wadden TA, Chao AM, Machineni S, Kushner R, Ard J, Srivastava G, Halpern B, Zhang S, Chen J, Bunck MC, Ahmad NN, Forrester T. Nature Medicine 2023

§1Bibliographic record

Authors: Wadden TA, Chao AM, Machineni S, Kushner R, Ard J, Srivastava G, Halpern B, Zhang S, Chen J, Bunck MC, Ahmad NN, Forrester T
Title: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
Source: Nature Medicine
Year: 2023
Volume, issue, pages: 29(11):2909–2918
Digital object identifier: 10.1038/s41591-023-02597-w
PubMed identifier: 37840095
Record type: Journal article
Institute identifier: CEI-BR-117

Table 1. Documents in the Institute set that cite this record.

Document	Series
Monograph: Tirzepatide	Compound monograph
Synthesis: Tirzepatide in obesity and overweight in adults: effect on the anchor…	Evidence synthesis
Synthesis: Tirzepatide in type 2 diabetes mellitus: effect on the anchor outcome	Evidence synthesis
Synthesis: Tirzepatide in atherosclerotic cardiovascular disease and…	Evidence synthesis
Synthesis: Tirzepatide in obstructive sleep apnoea with obesity: effect on the…	Evidence synthesis
Synthesis: Tirzepatide in obesity and overweight in adults: tolerability and…	Evidence synthesis
Synthesis: Tirzepatide in type 2 diabetes mellitus: tolerability and…	Evidence synthesis
Synthesis: Tirzepatide in atherosclerotic cardiovascular disease and…	Evidence synthesis
Synthesis: Tirzepatide in obstructive sleep apnoea with obesity: tolerability…	Evidence synthesis
Synthesis: Tirzepatide in obesity and overweight in adults: durability of effect	Evidence synthesis
Synthesis: Tirzepatide in type 2 diabetes mellitus: durability of effect	Evidence synthesis
11 citing documents.

tirzepatide lifestyle SURMOUNT

Compound Evidence Institute · CEI-BR-117 · https://compoundevidence.com/bibliography/wadden2023/ · retrieved 30 July 2026